Roivant Sciences Ltd (ROIV NASDAQ) stock market data APIs
$21.4171
-0.52(-2.4%)
as of November 12, 2025
Try our APIs with
free plan!
Roivant Sciences Ltd Financial Data Overview
Price chart is built with
Anychart
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.
Prev. Close
21.4171
Open
20.8977
High
21.1765
Low
20.8731
52 wk Range
8.73-21.35
Market Cap
14 536 M
Shares Outstanding
695 M
Revenue
20 329 K
EPS
-0.2758
Beta
1.229
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Roivant Sciences Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roivant Sciences Ltd data using free add-ons & libraries
Get Roivant Sciences Ltd Fundamental Data
Roivant Sciences Ltd Fundamental data includes:
- Net Revenue: 20 329 K
- EBITDA: -1 108 364 032
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-17
- EPS/Forecast: -0.3179
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roivant Sciences Ltd News
New
Roivant Sciences GAAP EPS of -$0.17 beats by $0.16, revenue of $1.57M misses by $5.35M
* Roivant Sciences press release [https://seekingalpha.com/pr/20300059-roivant-reports-financial-results-for-the-second-quarter-ended-september-30-2025-and-provides] (ROIV [https://seekingalpha.com/...
Roivant Reports Financial Results for the Second Quarter Ended September 30, 2025, and Provides Business Update
Roivant Sciences BASEL, Switzerland and LONDON and NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the second quarter ended September 30, ...
Stocks Recover on Government Reopening Hopes
The S&P 500 Index ($SPX) (SPY) on Friday closed up +0.13%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.16%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.28%. December E-m...
Stocks Recover on Government Reopening Hopes
The S&P 500 Index ($SPX) (SPY) on Friday closed up +0.13%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.16%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.28%. December E-m...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
